ID: MRFR/HC/7314-HCR | 125 Pages | Published By Kinjoll Dey on March 2023
The Global Cardiac Mapping Market is estimated to be USD 4.19 Billion growing at CAGR of 8.9% during forecast period of 2022-2030
$4.19 Billion
8.9%
North America
2022-2030
Report Attribute/Metric | Details |
---|---|
Market Size | USD 1179.81 Million |
CAGR | 8.20% |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Product, By Indication and By End-User |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Abbott Laboratories, GE Healthcare, Boston Scientific Corporation, Medtronic plc., Johnson & Johnson, Koninklijke Philips N.V., Hill-Rom Services, Inc., and others. |
Key Market Opportunities | An aging population and increasing incidence of cardiovascular diseases is expected to propel the cardiac mapping market. |
Key Market Drivers |
|
Cardiac mapping is the process of identifying the temporal and spatial distributions of myocardial electrical potentials during a heart rhythm
The product involved in Cardiac Mapping Market are Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems
The major key players of Cardiac Mapping Market are Abbott Laboratories, GE Healthcare, Boston Scientific Corporation, Medtronic plc., Johnson & Johnson, Koninklijke Philips N.V., Hill-Rom Services, Inc., and others.